Amarin Corp Plc (AMRN)

[lizzy241]

capt, page 8 can someone explain why the NHS uses inclisiran as a product then uses the same inclisiran in a different context such as a condition a person has. What am I missing?

They noted that several
treatments available in the NHS were used by only a small proportion of
people in REDUCE-IT or not at all. The adviser noted inclisiran, which is
recommended by NICE for treating primary hypercholesterolaemia or
mixed dyslipidaemia as an adjunct to diet in adults, was not a permitted
concomitant treatment in REDUCE-IT. Therefore, the effect of icosapent
ethyl on reducing the risk of cardiovascular disease in people who have
inclisiran is unknown. The clinical adviser also commented that standard